Journal of Cardio-Thoracic Medicine (Nov 2014)

Metabolic Syndrome in Chemical Warfare Patients with Chronic Obstructive Pulmonary Disease

  • Shahrzad M. Lari,
  • Davood Attaran,
  • Haleh RokniYazdi,
  • Mohammad Towhidi,
  • Omid Shadkam,
  • Abbas Asadi,
  • Mohammad Khajehdaluee,
  • Hossein Ayatollahi,
  • Majid Ghayour-Mobarhan

Journal volume & issue
Vol. 2, no. 4
pp. 231 – 237

Abstract

Read online

Introduction: Sulfur mustard (SM), a toxic alkylating gas, can cause serious long-term pulmonary complications such as chronic obstructive pulmonary disease (COPD). Metabolic syndrome (MetS) is one of the important comorbidities of COPD. This study was designed to evaluate the frequency of metabolic syndrome in Iranian chemical warfare patients (CWPs) with COPD. Materials and Methods: Thirty CWPs with a mean age of 46.93± 6.8 were enrolled in this study. The following parameters were studied in: complete pulmonary function tests, health-related quality of life, serum triglycerides (TG), high density lipoprotein (HDL) and fasting blood sugar (FBS) levels. Additionally, 32 COPD patients and 56 healthy persons were considered as control groups who were matched to CWPs. Results: We found a statistically significant difference in the frequency of MetS between the COPD patients and the healthy control group (p=0.04). Additionally, we observed a statistically significant difference in the mean HDL levels among these groups (p=

Keywords